Factors | disease-free survival rates | Hazard ratio | Â | Log-rank test p-value | |
---|---|---|---|---|---|
 | 10-year (%) | 95% CI a |  | 95% CI a |  |
Age | Â | Â | Â | Â | Â |
   < 35 | 47.0 | 33.3–60.7 | 1.00 | - | 0.49 |
   35–54 | 59.0 | 55.7–62.4 | 0.91 | 0.50–1.64 |  |
   ≥ 55 | 63.1 | 59.4–66.7 | 0.90 | 0.50–1.63 |  |
cTNM | Â | Â | Â | Â | Â |
   Stage I | 72.4 | 67.3–77.6 | 1.00 | - | <0.001 |
   Stage II | 60.9 | 58.0–63.9 | 2.05 | 1.45–2.91 |  |
   Stage III | 31.5 | 24.8–38.2 | 5.03 | 3.36–7.52 |  |
pTNM | Â | Â | Â | Â | Â |
   Stage I | 81.7 | 77.4–85.9 | 1.00 | - | <0.001 |
   Stage II | 67.5 | 64.4–70.5 | 2.18 | 1.47–3.24 |  |
   Stage III | 17.7 | 13.1–22.4 | 7.66 | 5.13–11.43 |  |
pN | Â | Â | Â | Â | Â |
   pN0 | 76.6 | 73.8–79.5 | 1.00 | - | <0.001 |
   pN1 | 56.4 | 51.6–61.2 | 1.85 | 1.36–2.53 |  |
   pN2 | 15.5 | 10.3–20.7 | 5.75 | 4.22–7.83 |  |
   pN3 | 26.8 | 16.6–37.1 | 4.88 | 3.25–7.32 |  |
ER status | Â | Â | Â | Â | Â |
   Negative | 59.8 | 56.4–63.2 | 1.00 | - | 0.183 |
   Positive | 60.0 | 56.6–63.4 | 0.83 | 0.63–1.09 |  |
Breast surgery | Â | Â | Â | Â | Â |
   Breast conserving surgery | 59.1 | 54.1–64.0 | 1.00 | - | 0.007 |
   Modified radical mastectomy | 61.5 | 58.7–64.3 | 1.14 | 0.86–1.52 |  |
   Standard radical mastectomy | NDb | - | 3.34 | 1.76–6.33 |  |